GlassScriptPhysician profile
Joshua A Klemp
NPI 1336363753
$4,479.67
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $1,606 · 2021: $2,115 · 2022: $508 · 2023: $26.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precision Spine, INC. | $3,645.73 | 2019-2021 | |
| Abbott Laboratories | $283.43 | 2019-2022 | |
| Aesculap, INC. | $134.99 | 2022 | |
| Kuros Biosciences USA, INC | $117.22 | 2022 | |
| Spinal Elements, INC. | $77.13 | 2019 | |
| Nevro Corp. | $70.94 | 2021 | |
| Kyocera Medical Technologies, INC. | $47.18 | 2022 | |
| Electronic Waveform Lab, INC. | $28.95 | 2019-2020 | |
| Acuity Surgical Devices, LLC | $26.97 | 2023 | |
| Spineology INC. | $19.10 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.48 | 2020 | |
| Orthofix Medical, INC. | $13.55 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Klemp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.